pI: 4.276 |
Length (AA): 2991 |
MW (Da): 295972 |
Paralog Number:
6
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 17 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
12 | 68 | 5cva (A) | 3 | 59 | 28.00 | 0.25 | 0.01 | 0.258357 | -0.12 |
163 | 339 | 4km7 (A) | 37 | 222 | 6.00 | 0.1 | 0 | 0.0914775 | -0.26 |
785 | 850 | 5cvw (A) | 1529 | 1588 | 42.00 | 0.24 | 0.26 | 0.432866 | -0.71 |
828 | 998 | 2ml3 (A) | 2 | 179 | 21.00 | 0 | 0.07 | 0.279272 | -0.87 |
830 | 1059 | 5c2m (A) | 20 | 248 | 11.00 | 0 | 0.01 | 0.152997 | -0.52 |
1172 | 1201 | 5cva (F) | 12 | 41 | 47.00 | 0.069 | 0.03 | 0.68983 | -2.13 |
1399 | 1607 | 5nb0 (A) | 7 | 214 | 42.00 | 0 | 1 | 0.514676 | 0.39 |
1634 | 1664 | 5cva (E) | 15 | 45 | 35.00 | 0 | 0.03 | 0.604464 | -2.7 |
1667 | 2171 | 5jou (A) | 309 | 813 | 7.00 | 0.36 | 0 | 0.18614 | -0.01 |
2168 | 2197 | 4auo (C) | 964 | 997 | 69.00 | 0.073 | 0.04 | 0.88883 | -2.91 |
2186 | 2267 | 2pne (A) | 2 | 81 | 39.00 | 0 | 0.92 | 0.628516 | -1.73 |
2549 | 2717 | 3tiq (A) | 433 | 609 | 34.00 | 0.54 | 0.13 | 0.151303 | 0.12 |
2693 | 2750 | 4mt2 (A) | 3 | 60 | 7.00 | 0.34 | 0 | 0.180692 | -1.45 |
2700 | 2816 | 2fj8 (A) | 6 | 122 | 7.00 | 0.39 | 0 | 0.0714174 | -0.16 |
2756 | 2984 | 5nb2 (B) | 6 | 227 | 49.00 | 0 | 0.95 | 0.167663 | 1.05 |
2756 | 2983 | 1t60 (C) | 5 | 225 | 43.00 | 0 | 1 | 0.559029 | 0.01 |
2756 | 2984 | 5nb2 (A) | 6 | 227 | 48.00 | 0 | 1 | 0.392363 | 0.48 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126592)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_16850 | collagen alpha 2(IV) chain precursor |
Brugia malayi | Bm1_57370 | Collagen alpha |
Caenorhabditis elegans | CELE_F01G12.5 | Protein LET-2, isoform B |
Caenorhabditis elegans | CELE_K04H4.1 | Protein EMB-9, isoform B |
Dictyostelium discoideum | DDB_G0277909 | calcium-binding protein |
Drosophila melanogaster | Dmel_CG42717 | CG42717 gene product from transcript CG42717-RA |
Drosophila melanogaster | Dmel_CG4145 | Collagen type IV |
Drosophila melanogaster | Dmel_CG16858 | viking |
Echinococcus granulosus | EgrG_000948400 | fibronectin type III domain-containing protein |
Echinococcus granulosus | EgrG_001060600 | Type II collagen B |
Echinococcus granulosus | EgrG_000144300 | Collagen alpha 1V chain |
Echinococcus granulosus | EgrG_000417600 | collagen alpha 1IV chain |
Echinococcus granulosus | EgrG_000203400 | Collagen alpha 1V chain |
Echinococcus granulosus | EgrG_000823800 | collagen alpha 2I chain |
Echinococcus granulosus | EgrG_000144400 | abnormal EMBroygenesis family member emb 9 |
Echinococcus granulosus | EgrG_002068400 | kunitz type serine protease inhibitor 6 |
Echinococcus granulosus | EgrG_001060700 | fibrillar collagen chain FAp1 alpha |
Echinococcus granulosus | EgrG_001190600 | collagen type i ii iii v xi alpha |
Echinococcus granulosus | EgrG_000144350 | collagen alpha 1(IV) chain |
Echinococcus granulosus | EgrG_000524200 | collagen type XI alpha 2 |
Entamoeba histolytica | EHI_059870 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000524200 | collagen type XI alpha 2 |
Echinococcus multilocularis | EmuJ_001060700 | fibrillar collagen chain FAp1 alpha |
Echinococcus multilocularis | EmuJ_000144350 | |
Echinococcus multilocularis | EmuJ_000203400 | Collagen alpha 1(V) chain |
Echinococcus multilocularis | EmuJ_001060600 | Type II collagen B |
Echinococcus multilocularis | EmuJ_000417600 | collagen alpha 1(IV) chain |
Echinococcus multilocularis | EmuJ_000139900 | abnormal EMBroygenesis family member (emb 9) |
Echinococcus multilocularis | EmuJ_000144400 | abnormal EMBroygenesis family member (emb 9) |
Echinococcus multilocularis | EmuJ_000823800 | collagen alpha 2(I) chain |
Echinococcus multilocularis | EmuJ_000140100 | Collagen alpha 1(V) chain |
Echinococcus multilocularis | EmuJ_000140000 | collagen alpha(iv) chain |
Echinococcus multilocularis | EmuJ_000144300 | Collagen alpha 1(V) chain |
Echinococcus multilocularis | EmuJ_001190600 | collagen type i II IIi v xi alpha collagen alpha (v) chain |
Homo sapiens | ENSG00000108821 | collagen, type I, alpha 1 |
Homo sapiens | ENSG00000114270 | collagen, type VII, alpha 1 |
Homo sapiens | ENSG00000188153 | collagen, type IV, alpha 5 |
Homo sapiens | ENSG00000171502 | collagen, type XXIV, alpha 1 |
Homo sapiens | ENSG00000169436 | collagen, type XXII, alpha 1 |
Homo sapiens | ENSG00000060718 | collagen, type XI, alpha 1 |
Homo sapiens | ENSG00000187498 | collagen, type IV, alpha 1 |
Homo sapiens | ENSG00000197565 | collagen, type IV, alpha 6 |
Homo sapiens | ENSG00000134871 | collagen, type IV, alpha 2 |
Homo sapiens | 1310 | collagen, type XIX, alpha 1 |
Homo sapiens | ENSG00000130635 | collagen, type V, alpha 1 |
Homo sapiens | ENSG00000080573 | collagen, type V, alpha 3 |
Homo sapiens | ENSG00000168542 | collagen, type III, alpha 1 |
Homo sapiens | ENSG00000204248 | collagen, type XI, alpha 2 |
Homo sapiens | 101929803 | adhesive plaque matrix protein-like |
Homo sapiens | ENSG00000164692 | collagen, type I, alpha 2 |
Homo sapiens | ENSG00000204262 | collagen, type V, alpha 2 |
Homo sapiens | ENSG00000139219 | collagen, type II, alpha 1 |
Homo sapiens | ENSG00000169031 | collagen, type IV, alpha 3 (Goodpasture antigen) |
Homo sapiens | ENSG00000196739 | collagen, type XXVII, alpha 1 |
Homo sapiens | ENSG00000084636 | collagen, type XVI, alpha 1 |
Homo sapiens | ENSG00000081052 | collagen, type IV, alpha 4 |
Leishmania mexicana | LmxM.14.1120b | |
Loa Loa (eye worm) | LOAG_09685 | hypothetical protein |
Loa Loa (eye worm) | LOAG_03919 | procollagen |
Loa Loa (eye worm) | LOAG_14600 | hypothetical protein |
Loa Loa (eye worm) | LOAG_09684 | hypothetical protein |
Mus musculus | 69700 | collagen, type XXII, alpha 1 |
Mus musculus | ENSMUSG00000026042 | collagen, type V, alpha 2 |
Mus musculus | ENSMUSG00000040690 | collagen, type XVI, alpha 1 |
Mus musculus | ENSMUSG00000031273 | collagen, type IV, alpha 6 |
Mus musculus | ENSMUSG00000031274 | collagen, type IV, alpha 5 |
Mus musculus | 12829 | collagen, type IV, alpha 4 |
Mus musculus | ENSMUSG00000031502 | collagen, type IV, alpha 1 |
Mus musculus | ENSMUSG00000025650 | collagen, type VII, alpha 1 |
Mus musculus | 12842 | collagen, type I, alpha 1 |
Mus musculus | ENSMUSG00000004098 | collagen, type V, alpha 3 |
Mus musculus | ENSMUSG00000027966 | collagen, type XI, alpha 1 |
Mus musculus | ENSMUSG00000031503 | collagen, type IV, alpha 2 |
Mus musculus | ENSMUSG00000026837 | collagen, type V, alpha 1 |
Mus musculus | ENSMUSG00000024330 | collagen, type XI, alpha 2 |
Mus musculus | 12823 | collagen, type XIX, alpha 1 |
Mus musculus | ENSMUSG00000079465 | collagen, type IV, alpha 3 |
Mus musculus | ENSMUSG00000022483 | collagen, type II, alpha 1 |
Mus musculus | ENSMUSG00000045672 | collagen, type XXVII, alpha 1 |
Mus musculus | ENSMUSG00000029661 | collagen, type I, alpha 2 |
Mus musculus | ENSMUSG00000028197 | collagen, type XXIV, alpha 1 |
Mus musculus | ENSMUSG00000026043 | collagen, type III, alpha 1 |
Mycobacterium ulcerans | MUL_4367 | PE-PGRS family protein |
Neospora caninum | NCLIV_049870 | GH22120, related |
Neospora caninum | NCLIV_035900 | RNA binding motif-containing protein, putative |
Neospora caninum | NCLIV_009210 | hypothetical protein |
Oryza sativa | 4328242 | Os02g0138000 |
Oryza sativa | 4343091 | Os07g0440100 |
Plasmodium knowlesi | PKNH_0946500 | SICAvar, type II |
Plasmodium knowlesi | PKNH_0300400 | SICAvar, type II |
Plasmodium vivax | PVX_118360 | TRAP-like protein |
Plasmodium yoelii | PY07368 | circumsporozoite protein precursor-related |
Schistosoma japonicum | Sjp_0011650 | ko:K06237 collagen, type IV, alpha, putative |
Schistosoma japonicum | Sjp_0034140 | ko:K06237 collagen, type IV, alpha, putative |
Schistosoma japonicum | Sjp_0003010 | Collagen alpha-2(I) chain precursor, putative |
Schistosoma japonicum | Sjp_0099350 | Collagen alpha-2(XI) chain precursor, putative |
Schistosoma japonicum | Sjp_0003000 | Collagen alpha-2(V) chain precursor, putative |
Schistosoma japonicum | Sjp_0034120 | ko:K06237 collagen, type IV, alpha, putative |
Schistosoma japonicum | Sjp_0000750 | Collagen alpha-2(V) chain precursor, putative |
Schistosoma japonicum | Sjp_0098850 | Collagen alpha-1(VI) chain precursor, putative |
Schistosoma japonicum | Sjp_0120520 | Collagen alpha-1(XXVII) chain precursor, putative |
Schistosoma japonicum | Sjp_0000760 | Collagen alpha-2(V) chain precursor, putative |
Schistosoma japonicum | Sjp_0081590 | Collagen alpha-3(V) chain precursor, putative |
Schistosoma japonicum | Sjp_0071880 | Collagen alpha-2(I) chain precursor, putative |
Schistosoma japonicum | Sjp_0034130 | Collagen alpha-1(IV) chain precursor, putative |
Schistosoma japonicum | Sjp_0300670 | Collagen alpha-2(I) chain precursor, putative |
Schistosoma japonicum | Sjp_0099360 | expressed protein |
Schistosoma mansoni | Smp_123830 | Collagen alpha-1(V) chain precursor |
Schistosoma mansoni | Smp_083630 | hypothetical protein |
Schistosoma mansoni | Smp_159600 | Collagen alpha-1(V) chain precursor |
Schistosoma mansoni | Smp_164590 | Collagen alpha-1(V) chain precursor |
Schistosoma mansoni | Smp_144910 | Collagen alpha-1(V) chain precursor |
Schistosoma mansoni | Smp_170340 | Collagen alpha-1(V) chain precursor |
Schistosoma mansoni | Smp_170330 | Collagen alpha-1(V) chain precursor |
Schmidtea mediterranea | mk4.003416.05 | |
Schmidtea mediterranea | mk4.001322.02 | |
Schmidtea mediterranea | mk4.000017.05 | |
Schmidtea mediterranea | mk4.013024.02 | |
Schmidtea mediterranea | mk4.001322.03 | |
Schmidtea mediterranea | mk4.008247.01 | |
Schmidtea mediterranea | mk4.000017.06 | |
Schmidtea mediterranea | mk4.000373.10 | |
Schmidtea mediterranea | mk4.000363.01 | |
Schmidtea mediterranea | mk4.003634.05 | |
Schmidtea mediterranea | mk4.004716.04 | |
Schmidtea mediterranea | mk4.005629.01 | |
Schmidtea mediterranea | mk4.010742.01 | |
Schmidtea mediterranea | mk4.003647.02 | |
Schmidtea mediterranea | mk4.005629.00 | |
Schmidtea mediterranea | mk4.016703.01 | |
Schmidtea mediterranea | mk4.013024.00 | Putative cuticle collagen 99 |
Schmidtea mediterranea | mk4.008247.00 | Putative cuticle collagen 99 |
Schmidtea mediterranea | mk4.005498.05 | |
Schmidtea mediterranea | mk4.012654.00 | |
Schmidtea mediterranea | mk4.016703.00 | |
Schmidtea mediterranea | mk4.005498.04 | |
Schmidtea mediterranea | mk4.000017.23 | Putative cuticle collagen 75 |
Schmidtea mediterranea | mk4.002029.01 | |
Trypanosoma brucei | Tb927.7.6580 | hypothetical protein |
Trypanosoma brucei | Tb927.7.6590 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_322700 | collagen, putative |
Toxoplasma gondii | TGME49_278800 | zinc finger protein 36 family 3 protein |
Toxoplasma gondii | TGME49_235420 | hypothetical protein |
Theileria parva | TP02_0895 | hypothetical protein |
Theileria parva | TP01_0967 | hypothetical protein |
Trichomonas vaginalis | TVAG_276200 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.6580 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.6580 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.6580 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.6580 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.7.6590 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.6590 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.6590 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.6590 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_K04H4.1 | Caenorhabditis elegans | adult lethal | wormbase |
CELE_K04H4.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_K04H4.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_K04H4.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_K04H4.1 | Caenorhabditis elegans | sterile | wormbase |
CELE_F01G12.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F01G12.5 | Caenorhabditis elegans | larval arrest | wormbase |
TGME49_235420 | Toxoplasma gondii | Probably essential | sidik |
TGME49_278800 | Toxoplasma gondii | Probably essential | sidik |
TGME49_322700 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.